Clinical data | Patients |
---|---|
Women/men | 66/34 |
Age, years ± SD | 45.35 ± 16.23 |
Systemic score, mean ± SD | 6.11 ± 2.02 |
Comorbidities, number (%) | 33 (33) |
Outcome | |
Favorable outcome, number (%) | 84 (84) |
Monocyclic course | 29 (29) |
Polycyclic course | 22 (22) |
Chronic course | 33 (33) |
Unfavorable outcome, number (%) | 16 (16) |
AOSD-related death | 16 (16) |
Time of follow-up, years (mean ± SD) | 3.53 ± 2.93 |
Median survival time (25%, 75%), years | 2.5 (1.8–5) |